MedPath

MELROSE LABORATORIES PTY. LTD.

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

35

TGA:35

Drug Approvals

Melrose FutureLab Time Capsule Daily Longevity Complex (491947)

Product Name
Melrose FutureLab Time Capsule Daily Longevity Complex
Approval Date
Jun 17, 2025
TGA

Melrose FutureLab 3-in-1 Longevity Complex (489278)

Product Name
Melrose FutureLab 3-in-1 Longevity Complex
Approval Date
May 20, 2025
TGA

Melrose FutureLab Omega-3-11 Ultra Complex (486067)

Product Name
Melrose FutureLab Omega-3-11 Ultra Complex
Approval Date
Apr 15, 2025
TGA

Melrose FutureLab Total Body Collagen (481727)

Product Name
Melrose FutureLab Total Body Collagen
Approval Date
Mar 5, 2025
TGA

Melrose FutureLab Testosterone Matrix (480769)

Product Name
Melrose FutureLab Testosterone Matrix
Approval Date
Feb 25, 2025
TGA

Melrose FutureLab Peri Meno Ultra Complex (462354)

Product Name
Melrose FutureLab Peri Meno Ultra Complex
Approval Date
Sep 18, 2024
TGA

Melrose FutureLab Menopause Ultra Complex (462353)

Product Name
Melrose FutureLab Menopause Ultra Complex
Approval Date
Sep 18, 2024
TGA

Melrose FutureLab Vascular Health (451258)

Product Name
Melrose FutureLab Vascular Health
Approval Date
Jun 6, 2024
TGA

Melrose FutureLab Muscle Protein Complex (449207)

Product Name
Melrose FutureLab Muscle Protein Complex
Approval Date
May 21, 2024
TGA

Melrose FutureLab Inflammation Modulator (448951)

Product Name
Melrose FutureLab Inflammation Modulator
Approval Date
May 17, 2024
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.